Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

VIEWS: 40 PAGES: 19

Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology company, based in the US. It develops drugs for the treatment of inflammatory and thrombotic diseases. The company aims at binding two proteins, P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Selexys Pharmaceuticals’ product pipeline includes Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating inflammation and Anti-PSGL-1, a monoclonal antibodies targeted at inflammatory bowel diseases. Its Research and Development (R&D) activities are directed towards the preclinical development of antibody-based therapeutics for treating inflammation. Selexys Pharmaceuticals is headquartered in Oklahoma City, Oklahoma, the US.

More Info
									                    Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare -
                                        Deals and Alliances Profile
       Reference Code: GDPH137612D                                                                                                           Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology
                                                                                                              Selexys Pharmaceuticals Corporation,
      company, based in the US. It develops drugs for the treatment of inflammatory and
                                                                                                              Pharmaceuticals & Healthcare, Key Facts
      thrombotic diseases. The company aims at binding two proteins, P-selectin and
      PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic                                Web Address                      www.selexys.com
      disorders. Selexys Pharmaceuticals’ product pipeline includes Anti-P-selectin, which
                                                                                                               Revenue (US$ million)                         NA
      blocks selectin function and prevents white blood cells from initiating inflammation
      and Anti-PSGL-1, a monoclonal antibodies targeted at inflammatory bowel diseases.                        Number of Employees                           NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Selexys Pharmaceuticals Corporation, Pharmaceuticals &                            Selexys Pharmaceuticals Corporation, Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                                                       2
                                                                                                          2


                                                                                           No. of Deals                          1       1      1
                                                                                                          1


                                                                                                                 0      0                                     0
                                                                                                          0
                                                                                                               2007    2008   2009     2010    2011   2012   YTD
                                                                                                                                                             2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Selexys Pharmaceuticals Corporation, Pharmaceuticals &                           Selexys Pharmaceuticals Corporation, Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         6     5                                                                          6
                                                                                                                        5
          No. of Deals




                         5
                                                                                                          5
                         4                                                                                                               4             4
                                                                                           No. of Deals




                         3                                                                                4
                         2                                                                                3
                         1              0         0        0         0
                         0                                                                                2
                             North    Asia-     Europe   Middle   South                                   1
                             Americ   Pacific             East     and
                               a                          and     Central                                 0
                                                         Africa   Americ                                             Immunolog       Cardiovasc Hematologi
                                                                    a                                                    y              ular    cal D isord …


         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Selexys Pharmaceuticals Corporation - Pharmaceuticals &                                                                                       Reference Code: GDPH137612D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ...................................... 3
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ...................................... 5
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................. 6
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ........................ 7
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs
       Upfront Payment, 2007 to YTD 2013 ................................................................................................................................................. 8
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................... 9
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deal Details ...................................................................... 10
          Venture Financing......................................................................................................................................................................... 10
             Selexys Pharma Raises $23 Million In Series A Financing ....................................................................................................... 10
             Selexys Pharma Secures Additional $2.2 Million In Venture Financing .................................................................................... 11
             Selexys Pharma Secures $3.5 Million In Seed Financing ......................................................................................................... 12
          Partnerships.................................................................................................................................................................................. 13
             Cytovance Biologics Enters Into Co-Development Agreement With Selexys Pharma .............................................................. 13
          Acquisition .................................................................................................................................................................................... 14
             Novartis Pharma To Acquire Selexys Pharma For Up To $665 Million ..................................................................................... 14
       Selexys Pharmaceuticals Corporation - Key Competitors ................................................................................................................ 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       Appendix .......................................................................................................................................................................................... 19
          Methodology ................................................................................................................................................................................. 19
          About GlobalData ......................................................................................................................................................................... 19
          Contact Us .................................................................................................................................................................................... 19
          Disclaimer ..................................................................................................................................................................................... 19




Selexys Pharmaceuticals Corporation - Pharmaceuticals &                                                                                                          Reference Code: GDPH1376
								
To top